Interestingly, similarly treated ID8-Trp53(−/−)Brca2(−/−)* tumours did benefit from olaparib treatment (Fig. 2h), but the effect was at best as high as postulated for the sole effect of olaparib cytotoxicity. The gene discussed is BRCA2; the disease is neoplasm.